| KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia LD Boila, SS Chatterjee, D Banerjee, A Sengupta Experimental hematology 58, 44-51. e7, 2018 | 34 | 2018 |
| MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia M Biswas, SS Chatterjee, LD Boila, S Chakraborty, D Banerjee, ... The FASEB Journal 33 (4), 5268-5286, 2019 | 29 | 2019 |
| SMARCB1 deficiency integrates epigenetic signals to oncogenic gene expression program maintenance in human acute myeloid leukemia SS Chatterjee, M Biswas, LD Boila, D Banerjee, A Sengupta Molecular Cancer Research 16 (5), 791-804, 2018 | 27 | 2018 |
| Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy LD Boila, A Sengupta Experimental hematology 92, 19-31, 2020 | 11 | 2020 |
| Rad26, the transcription-coupled repair factor in yeast, is required for removal of stalled RNA polymerase-II following UV irradiation S Ghosh-Roy, D Das, D Chowdhury, M J. Smerdon, RN Chaudhuri PloS one 8 (8), e72090, 2013 | 10 | 2013 |
| KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition LD Boila, S Ghosh, SK Bandyopadhyay, L Jin, A Murison, AGX Zeng, ... Leukemia 37 (4), 751-764, 2023 | 6 | 2023 |
| A potent conformation-constrained synthetic peptide mimic of a homeodomain selectively regulates target genes in cells B Ghosh, LD Boila, S Choudhury, P Mondal, S Bhattacharjee, SK Pal, ... ACS chemical biology 13 (8), 2003-2009, 2018 | 2 | 2018 |
| KDM6A loss sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition LD Boila, S Ghosh, SK Bandyopadhyay, L Jin, A Murison, AGX Zeng, ... bioRxiv, 2022.07. 12.498585, 2022 | 1 | 2022 |
| miRNA and Cancer: A Deadly Liaison? S Sinha, LD Boila, SS Chatterjee, A Sengupta Cancer and Noncoding RNAs, 27-46, 2018 | 1 | 2018 |
| SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma IS Luk, CM Bridgwater, A Yu, LD Boila, M Yáñez-Bartolomé, AE Lampano, ... Science Translational Medicine 16 (747), eadj7685, 2024 | | 2024 |
| Unifying targeted therapy for leukemia in the era of PARP inhibition LD Boila, A Sengupta Experimental Hematology 124, 1-14, 2023 | | 2023 |
| KDM6 Demethylases Integrate DNA Repair Gene Regulation: Loss of KDM6A Sensitizes AML to PARP Inhibition and Potentiates with BCL2 Blockade LD Boila, L Jin, A Murison, SK Bandyopadhyay, S Ghosh, ... Blood 138, 25, 2021 | | 2021 |
| UTX and MBD3 Epistasis Regulates Rac Gtpase Activation and Sensitizes Human Acute Myeloid Leukemia Cells to Dock Inhibition SS Chatterjee, M Biswas, LD Boila, S Chakraborty, S Sinha, D Banerjee, ... Blood 132, 3880, 2018 | | 2018 |
| Epigenetic Plasticity in ATP-Dependent Chromatin Remodeling Complexes in Human Acute Myeloid Leukemia M Biswas, SS Chatterjee, LD Boila, D Banerjee, A Sengupta Blood 130, 3801, 2017 | | 2017 |
| Deciphering chromatin remodeling in myelodysplastic syndrome SS Chatterjee, M Biswas, LD Boila, S Sinha, S Chakraborty, D Banerjee, ... EUROPEAN JOURNAL OF CANCER 54, S46-S46, 2016 | | 2016 |
| Histone Demethylases in Myeloid Leukemia LD Boila Kolkata, 0 | | |
Amitava SenguptaAssistant Professor, Senior Scientist, Stem Cell & Leukemia Lab, Indian Institute of Chemical在 iicb.res.in 的电子邮件经过验证
